Hong Kong: China’s leading CRO plans HKEx listing

Joinn Laboratories, the largest CRO in non-clinical drug safety assessment in China, has filed to float on the Hong Kong Stock Exchange. It is already listed in Shanghai. Founded in 1995 and headquartered in Beijing, the leading CRO in China in terms of the size of GLP-compliant facilities currently owns and operate two GLP-certified facilities…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »